Enlicitide chloride

• Target:

  Serine Protease

• Related Pathways:

  Proteases/Proteasome

• Bioactivity:

  Enlicitide chloride is an effective PCSK9 antagonist. It is utilized in the research of cardiovascular diseases such as atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or associated cardiovascular and cardiac metabolic disorders.

• Smiles:

  FC=1C=C2C3=CN (C2=CC1) CCCCCCN4CC=5C=CC (=CC5) CCNC (=O) [C@@]6 (C) N (C (=O) [C@H] (CC7=CC=C (OC) C=C7) NC (=O) [C@] ([C@@H] (C) O) (NC (=O) [C@]8 (N9C (=O) [C@] (C3) (NC (=O) [C@] (CC=%10C=C (C=CC%10) CNC (=O) CO[C@]8 (CC9) [H]) (NC (=O) [C@@H] (CNC (CCCCC[N+] (C) (C) C) =O) NC (=O) [C@H] (C) NC (=O) CCC4=O) [H]) [H]) [H]) [H]) CCC6.[Cl-]

• Molecular Formula:

  C82H110ClFN14O15

• Molecular Weight:

  1586.29

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2407527-16-4